Cornell University

Precipio Announces Christina Valauri joins the Board of Directors

Retrieved on: 
Tuesday, January 2, 2024

NEW HAVEN, Conn., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is pleased to welcome Christina Valauri to its board of directors effective Jan 1st, 2024.

Key Points: 
  • NEW HAVEN, Conn., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is pleased to welcome Christina Valauri to its board of directors effective Jan 1st, 2024.
  • Ms. Valauri is the founding partner and CEO of Sagestone Advisory, LLC.
  • Ms. Valauri earned her BA in Biology from Reed College and an MBA from Cornell University.
  • We are fortunate to have her join our board.”
    After serving on Precipio’s board of directors for 6 years, Douglas Fisher, MD is stepping off the board to maintain a board of 7 directors and will remain as an observer moving forward.

2023 Urology Care Foundation Research Scholar Awardees Announced

Retrieved on: 
Tuesday, December 19, 2023

BALTIMORE, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The American Urological Association (AUA) and the Urology Care Foundation, the official foundation of the AUA, are pleased to recognize 13 researchers as recipients of the 2023 Urology Care Foundation Research Scholar Awards.

Key Points: 
  • BALTIMORE, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The American Urological Association (AUA) and the Urology Care Foundation, the official foundation of the AUA, are pleased to recognize 13 researchers as recipients of the 2023 Urology Care Foundation Research Scholar Awards.
  • Research Scholar Awards support future research leaders and ensure they receive the necessary training and guidance for a successful research career.
  • "The Urology Care Foundation is dedicated to improving urologic health worldwide by supporting research, providing patient education materials, and promoting humanitarian initiatives,” said Harris M Nagler, MD, FACS, Urology Care Foundation President.
  • “We are proud of our 2023 awardees and recognize the substantial impact their work will have on advancing the field of urology.”
    To learn more about the Urology Care Foundation Research Scholar Awards visit: https://www.auanet.org/research-and-data/research-awards/aua-funding/res...

NewHydrogen CEO Steve Hill Discusses Hydrogen's Role in Future Fuels with Georgia Tech Energy and Environment Expert

Retrieved on: 
Tuesday, December 19, 2023

SANTA CLARITA, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- NewHydrogen, Inc. (OTCMKTS:NEWH), the developer of a breakthrough technology that uses clean energy and water to produce the world’s cheapest green hydrogen, today announced that in a recent podcast the Company’s CEO Steve Hill spoke with Dr. Valerie M. Thomas, Georgia Tech Andersen Interface Chair of Natural Systems in the H. Milton Stewart School of Industrial and Systems Engineering and in the School of Public Policy regarding the challenges and opportunities in evaluating the carbon footprint of different fuels. Their discussion provided a comprehensive overview of the current state and future possibilities of hydrogen as a pivotal component in the global transition to sustainable energy.

Key Points: 
  • Their discussion provided a comprehensive overview of the current state and future possibilities of hydrogen as a pivotal component in the global transition to sustainable energy.
  • The podcast began with an exploration of the complexities surrounding the assessment of carbon footprints, especially in the context of low carbon fuel standards.
  • Mr. Hill expressed enthusiasm about these groundbreaking developments and delved into the process of deconstructing ammonia back into hydrogen.
  • Mr. Hill and Dr. Thomas painted an optimistic picture of a future where sustainable and innovative energy solutions play a central role in addressing global energy challenges.

Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia

Retrieved on: 
Thursday, December 14, 2023

The first dose cohort consisted of a starting dose of 20 mg/m2, and there were no dose limiting toxicities.

Key Points: 
  • The first dose cohort consisted of a starting dose of 20 mg/m2, and there were no dose limiting toxicities.
  • The approved treatment cycle is two doses per week over four weeks for a total of eight doses administered over twenty-eight days.
  • The Phase 1b portion of the study is expected to commence after completion of BP1002 monotherapy cohorts and will assess the safety and efficacy of BP1002 in combination with decitabine in refractory/relapsed AML patients.
  • Gail J. Roboz, M.D., is the National Principal Investigator for the Phase 1/1b trial.

General Atomics Brings Inertial Fusion Energy Expertise to Two National Research Hubs

Retrieved on: 
Friday, December 8, 2023

San Diego, CA, Dec. 08, 2023 (GLOBE NEWSWIRE) -- General Atomics (GA) has been selected as a team member for two science and technology hubs funded by the U.S. Department of Energy (DOE)’s Inertial Fusion Energy Science & Technology Accelerated Research ( IFE-STAR ) program to advance IFE science and technologies.

Key Points: 
  • San Diego, CA, Dec. 08, 2023 (GLOBE NEWSWIRE) -- General Atomics (GA) has been selected as a team member for two science and technology hubs funded by the U.S. Department of Energy (DOE)’s Inertial Fusion Energy Science & Technology Accelerated Research ( IFE-STAR ) program to advance IFE science and technologies.
  • The STARFIRE and RISE hubs will each receive $16 million each over the next four years.
  • IFE is currently the only fusion approach to have achieved net energy gain in a laboratory, after achieving a 1.5x energy gain at LLNL’s National Ignition Facility (NIF) in December 2022.
  • Other collaborators working on the RISE hub include CSU, Stanford & SLAC National Accelerator Lab, University of Illinois, Cornell University, Texas A&M, Los Alamos National Lab (LANL), Naval Research Lab (NRL), Marvel Fusion (MF), and Xcimer Energy.

It’s Time to Explore Japanese Culture in The Palm Beaches: History, Art, Cuisine, and More

Retrieved on: 
Wednesday, December 6, 2023

Today, The Palm Beaches continues to recognize its international roots by celebrating Japanese culture throughout the community.

Key Points: 
  • Today, The Palm Beaches continues to recognize its international roots by celebrating Japanese culture throughout the community.
  • From visiting the stunning new exhibition to immersive art, music, and history lessons, there are numerous opportunities to experience Japanese culture in The Palm Beaches.
  • Learn about some of the organizations spotlighting Japanese culture in 2023 and 2024 below.
  • Morikami Museum and Japanese Gardens (Delray Beach): The Morikami Museum and Japanese Gardens is a center for Japanese arts and culture in South Florida.

STRATA Skin Science Announces Strengthening of Leadership Team

Retrieved on: 
Monday, December 4, 2023

HORSHAM, Pa., Dec. 04, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the promotion of Shmuel Gov to Chief Operating Officer. The Company has also hired Dr. Amandeep Kaur as Vice President of Marketing and Business Growth.

Key Points: 
  • His outstanding leadership, strategic insight, and continued commitment to our mission make him the ideal choice to drive our operational excellence.
  • Together, we will reach new heights and achieve success in our shared journey,” expressed Shmuel Gov, Chief Operating Officer of STRATA.
  • Additionally, Dr. Amandeep Kaur has rejoined STRATA and brings years of experience and background in business development, marketing, and technology.
  • Her close ties with the clinical and research community and her experience as a business development leader will help STRATA accomplish its near-term turn-around goals.”

Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator

Retrieved on: 
Thursday, November 30, 2023

CAMBRIDGE, Mass., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a biopharmaceutical company on a mission to develop treatments for serious diseases, today announced the appointments of Dina Katabi, Ph.D., and Michael Higgins to its Board of Directors.

Key Points: 
  • “Dina and Michael bring a unique combination of leadership capabilities, operating experience, and vast cutting-edge scientific knowledge.
  • Having a world-renowned innovator and a biopharma veteran join the board facilitates the transformation of Cyclerion as we look ahead to possible licenses, mergers, acquisitions and/or other targeted investments,” said Errol DeSouza, Ph.D., chairperson of Cyclerion Therapeutics.
  • She is the co-founder and president of Emerald Innovations, a health analytics company that specializes in digital health solutions for passive, contactless, in-home monitoring.
  • Mr. Higgins has been a long-time board member and board chair at other public and private companies.

HII Announces New Chief Information Officer at Mission Technologies

Retrieved on: 
Thursday, November 30, 2023

NEWPORT NEWS, Va., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Global all-domain defense provider HII (NYSE: HII) announced today that Marc Sosa has been named as chief information officer for its Mission Technologies division.

Key Points: 
  • NEWPORT NEWS, Va., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Global all-domain defense provider HII (NYSE: HII) announced today that Marc Sosa has been named as chief information officer for its Mission Technologies division.
  • He will report to Chris Soong, HII’s executive vice president and chief information officer, and also will have reporting responsibilities to Andy Green, HII’s executive vice president and president of Mission Technologies.
  • Sosa will be responsible for all aspects of information technology to enable Mission Technologies’ IT priorities and meet strategic objectives.
  • He will guide the division’s day-to-day leadership of all information systems, while ensuring the appropriate alignment with enterprise cybersecurity and IT goals.

Swayable Awarded U.S. Patent for Persuasion Measurement Technology

Retrieved on: 
Wednesday, November 29, 2023

NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Swayable , the company behind the data platform used by the world’s major marketers to pre-test advertising messages, has received a United States Patent for its proprietary technology.

Key Points: 
  • NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Swayable , the company behind the data platform used by the world’s major marketers to pre-test advertising messages, has received a United States Patent for its proprietary technology.
  • The platform greatly enhances these measurements through proprietary machine-learning population models that deliver its Swayable Impact Scores.
  • Swayable is powering a major shift in how marketers use data to tell more persuasive stories that boost brand lift.
  • Swayable is backed by top technology and social impact investors, including Y Combinator.